Innoviva: Underappreciated Strength In Hospital Therapeutics
Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...
GSK plc (GSK): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going ...
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - GSK
Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive ...
Levi & Korsinsky Notifies Shareholders of GSK plc(GSK) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / February 22, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
Why AbbVie Remains A Strong Buy For Long-Term Investors
Second, with a strong focus on the immunology market, which, as I discussed in the article "Top 4 Immunology Stocks Poised ...
The Guardian Nigeria1h
Stakeholders urge Pfizer to be fair in compensation of staff
Once people don’t have justifiable access to medicine, the disease will stay longer with those people. Some will end up dying ...
Le Lézard22m
Global Influenza Vaccine Market is Projected to Cross USD 14 Billion Mark by 2032 | DelveInsight
The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination. The ...
Emma Walmsley Sells 38,459 Shares of GSK plc (LON:GSK) Stock
GSK plc (LON:GSK – Get Free Report) insider Emma Walmsley sold 38,459 shares of the stock in a transaction dated Monday, February 17th. The stock was sold at an average price of GBX 1,418 ($17.92), ...